Skip to main content
Livermore
Livermore
ZHEN

Commonwealth Equity Services, LLC

SEC CIK
0000312272
Latest filing
Jul 29, 2026

LCTX holding history

Lineage Cell Therapeutics, Inc. in every 13F filed by Commonwealth Equity Services, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LCTX overviewAll 13F holders of LCTXFull Q2 2026 holdings

Shares (Q2 2026)
102,178
Value
$133.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of LCTX by Commonwealth Equity Services, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026102,178$133.8K<0.1%−650−0.6%ReducedHolders
Q1 2026102,828$162.5K<0.1%−1,439−1.4%ReducedHolders
Q4 2025104,267$174.1K<0.1%+3,345+3.3%AddedHolders
Q3 2025100,922$171.0K<0.1%+39,400+64.0%AddedHolders
Q2 202561,522$56.0K<0.1%+2,814+4.8%AddedHolders
Q1 202558,708$27.0K<0.1%00.0%UnchangedHolders
Q4 202458,708$30.0K<0.1%+10,447+21.6%AddedHolders
Q3 202448,261$44.0K<0.1%+500+1.0%AddedHolders
Q2 202447,761$48.0K<0.1%00.0%UnchangedHolders
Q1 202447,761$71.0K<0.1%00.0%UnchangedHolders
Q4 202347,761$52.0K<0.1%−6,721−12.3%ReducedHolders
Q3 202354,482$64.0K<0.1%+3,000+5.8%AddedHolders
Q2 202351,482$73.0K<0.1%+2,993+6.2%AddedHolders
Q1 202348,489$72.0K<0.1%−500−1.0%ReducedHolders
Q4 202248,989$57.0K<0.1%+5,999+14.0%AddedHolders
Q3 202242,990$48.0K<0.1%−2,500−5.5%ReducedHolders
Q2 202245,490$71.0K<0.1%+10.0%AddedHolders
Q1 202245,489$70.0K<0.1%+6,860+17.8%AddedHolders
Q4 202138,629$94.0K<0.1%−5,310−12.1%ReducedHolders
Q3 202143,939$110.0K<0.1%−10,400−19.1%ReducedHolders
Q2 202154,339$154.0K<0.1%+6,014+12.4%AddedHolders
Q1 202148,325$113.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.